Informação sobre produto
Nome:Sodium 4-Aminophenylarsonate
Marca:Biosynth
Descrição:Sodium 4-aminophenylarsonate (APA) is a potential biomarker for the treatment of atherosclerosis. It is an enzyme that catalyzes the degradation of nonsteroidal anti-inflammatory drugs (NSAIDs). APA also has kinetic energy and can be used as a model system for studying mitochondrial membrane potential and locomotor activity.
Sodium 4-aminophenylarsonate (APA) is a potential biomarker for the treatment of atherosclerosis. It is an enzyme that catalyzes the degradation of nonsteroidal anti-inflammatory drugs (NSAIDs). APA also has kinetic energy and can be used as a model system for studying mitochondrial membrane potential and locomotor activity.
Sodium 4-aminophenylarsonate (APA) is a potential biomarker for the treatment of atherosclerosis. It is an enzyme that catalyzes the degradation of nonsteroidal anti-inflammatory drugs (NSAIDs). APA also has kinetic energy and can be used as a model system for studying mitochondrial membrane potential and locomotor activity.
Aviso:Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Propriedades químicas
Peso molecular:239.04 g/mol
Fórmula:C6H7AsNNaO3
Pureza:Min. 95%